ArticleDiagnostics (Basel, Switzerland)2023
Precision in Dermatology: Developing an Optimal Feature Selection Framework for Skin Lesion Classification.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- XAI-MedNet: A Next-Generation Explainable AI Framework for Contrast-Enhanced Skin Lesion Classification via Entropy-Controlled Optimization.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Melanoma is widely recognized as one of the most lethal forms of skin cancer, with its incidence showing an upward trend in recent years. Nonetheless, the timely detection of this malignancy substantially enhances the likelihood of patients' long-term survival. Several computer-based methods have recently been proposed, in the pursuit of diagnosing skin lesions at their early stages. Despite achieving some level of success, there still remains a margin of error that the machine learning community considers to be an unresolved research challenge. The primary objective of this study was to maximize the input feature information by combining multiple deep models in the first phase, and then to avoid noisy and redundant information by downsampling the feature set, using a novel evolutionary feature selection technique, in the second phase. By maintaining the integrity of the original feature space, the proposed idea generated highly discriminant feature information. Recent deep models, including Darknet53, DenseNet201, InceptionV3, and InceptionResNetV2, were employed in our study, for the purpose of feature extraction. Additionally, transfer learning was leveraged, to enhance the performance of our approach. In the subsequent phase, the extracted feature information from the chosen pre-existing models was combined, with the aim of preserving maximum information, prior to undergoing the process of feature selection, using a novel entropy-controlled gray wolf optimization (ECGWO) algorithm. The integration of fusion and selection techniques was employed, initially to incorporate the feature vector with a high level of information and, subsequently, to eliminate redundant and irrelevant feature information. The effectiveness of our concept is supported by an assessment conducted on three benchmark dermoscopic datasets: PH2, ISIC-MSK, and ISIC-UDA. In order to validate the proposed methodology, a comprehensive evaluation was conducted, including a rigorous comparison to established techniques in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.